Mercer
Coverage of Mercer in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
An FDA advisory panel recommended Replimune's experimental melanoma drug RP1 after a 10-3 vote, but the weight loss drug market shows signs of slowing as employers and insurers reduce coverage. The FDA's new leadership is being observed for its approach to evaluating investigational drugs.
- Air Quality Alert issued for portions of New Jersey
A Code Orange Air Quality Alert has been issued for Middlesex, Monmouth, and Mercer counties in New Jersey by the Department of Environmental Protection. The alert, indicating potentially unhealthy air pollution levels, remains in effect through Wednesday evening.
- Goldman Sachs wins $70 billion in asset management deals with Verizon, Lockheed Martin
Goldman Sachs secured $70 billion in asset management deals with Verizon and Lockheed Martin. The competition in the retirement assets market includes managers like Goldman Sachs, BlackRock, Russell Investments, and Mercer.
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and more
Some employers plan to drop coverage of GLP-1 weight loss drugs in 2027 as usage rises, despite lower prices for medications like Novo Nordisk’s Zepbound and Eli Lilly’s Foundayo. Rapid adoption of GLP-1 drugs in the U.K. has reduced annual grocery spending by $1 billion, with 6.3% of households now including at least one user.
- America's work perk boom meets reality
The era of expanding workplace perks is ending due to rising health-care costs and AI spending, with companies like Deloitte and Zoom rolling back benefits such as paid parental leave and retirement matches. This shift is a result of economic and labor market realities undergoing a drastic change. Companies are reevaluating the total benefits they can afford.